New England Research & Management, Inc. Penumbra Inc Transaction History
New England Research & Management, Inc.
- $213 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding PEN
# of Institutions
373Shares Held
29.1MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$884 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$477 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$372 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$297 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.11B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...